CAS No. 872713-04-7

Piperazine,1-[[6-[(2R)-3-(4-fluorophenyl)-2-methylpropoxy]-3,4-dihydro-1-methyl-2-naphthalenyl]methyl]-4-(phenylmethyl)-

Catalog No.	2426151
Name	Piperazine,1-[[6-[(2R)-3-(4-fluorophenyl)-2-methylpropoxy]-3,4-dihydro-1-methyl-2-naphthalenyl]methyl]-4-(phenylmethyl)-
CAS	872713-04-7
Formula	C33H39FN2O

Methyl Propoxy 4-Fluorophenyl

Request a Quote SDS

About Piperazine,1-[[6-[(2R)-3-(4-fluorophenyl)-2-methylpropoxy]-3,4-dihydro-1-methyl-2-naphthalenyl]methyl]-4-(phenylmethyl)-

Piperazine,1-[[6-[(2R)-3-(4-fluorophenyl)-2-methylpropoxy]-3,4-dihydro-1-methyl-2-naphthalenyl]methyl]-4-(phenylmethyl)- is a chemical compound registered under CAS number 872713-04-7, with the molecular formula C33H39FN2O and a molecular weight of about 498.69 g/mol. KingPharm Group supplies Piperazine,1-[[6-[(2R)-3-(4-fluorophenyl)-2-methylpropoxy]-3,4-dihydro-1-methyl-2-naphthalenyl]methyl]-4-(phenylmethyl)- for laboratory research and bulk production; product code 2426151. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 872713-04-7
Molecular Formula: C33H39FN2O
Molecular Weight: 498.69 g/mol

Related Keywords

piperazine

fluorophenyl

naphthalenyl

phenylmethyl

methylpropoxy

Piperazine,

ACETAMIDE,N-(4-METHYL-THIAZOL-2-YL)-2-(1,2,4-TRIAZOLO[4,3-A]PYRIMIDIN-3-YLTHIO)-

PIPERAZINE,1-ETHYL-4-[4-(1-PYRROLIDINYLSULFONYL)BENZOYL]-

2H-Pyran, tetrahydro-3,4,4-trimethoxy-

ACETAMIDE,N-CYCLOPROPYL-2-[[6-ETHYL-2-(4-FLUOROPHENYL)-4-QUINAZOLINYL]THIO]-

7-Hexadecenoic acid, methyl ester, (E)-

PIPERAZINE,1-[(2-ETHYL-2,3-DIHYDRO-6-METHYL-3-OXO-4H-1,4-BENZOXAZIN-4-YL)ACETYL]-4-(2-FLUOROPHENYL)-

606120-32-5

PYRIMIDO[1,2-A]BENZO[D]IMIDAZOL-4-AMINE,N-(3,4-DIFLUOROPHENYL)-2-METHYL-

4H-BENZO[B][1,4]OXAZINE-4-ACETAMIDE,N-[(2-CHLORO-6-FLUOROPHENYL)METHYL]-2-ETHYL-2,3-DIHYDRO-6-METHYL-3-OXO-N-(PYRIDIN-3-YLMETHYL)-

AZIRIDINONE, 1-CYCLOHEXYL-

PROPANAMIDE,N-[4-[2,3-DIHYDRO-1-(2-METHYL-1-OXOPROPYL)-1H-INDOL-5-YL]-5-METHYL-THIAZOL-2-YL]-2-METHYL-

ACETAMIDE,N-[4-(TERT-BUTYL)-THIAZOL-2-YL]-2-[(5,7-DIMETHYL-1,2,4-TRIAZOLO[4,3-A]PYRIMIDIN-3-YL)THIO]-

1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 6-hydroxy-1-oxo-

62473-91-0

9H-Carbazole,9-[4-[(1E)-2-[4-[(1E)-2-(2-benzothiazolyl)ethenyl]phenyl]ethenyl]phenyl]-

UREA, N-[4-(METHYLTHIO)PHENYL]-N-4-MORPHOLINYL-

PIPERIDINE,1-[[(6-ETHYL-2-PHENYL-4-QUINAZOLINYL)THIO]ACETYL]-

ACETAMIDE,2-[[2-(4-FLUOROPHENYL)-8-METHYL-4-QUINAZOLINYL]THIO]-N-(ISOPROPYL)-

5-QUINOXALINECARBOXAMIDE,N-(2-THIENYLMETHYL)-

H-SER-GLY-ALA-LEU-PRO-PRO-ALA-PRO-ALA-ALA-PRO-ARG-PRO-ALA-LEU-ARG-ALA-GLN-ARG-ALA-GLY-PRO-ALA-GLY-PRO-GLY-ALA-LYS-NH2

624735-22-4

2-Butylpyrimido[1,2-a]benzimidazol-4-ol

Furo[2,3-g]quinoline-7-carboxylic acid,5-(1-butenyl)-2,3,5,8-tetrahydro-8-oxo-

Benzenesulfonamide, 3-fluoro-4-hydrazino-

1H-Pyrazole-3-carboxylic acid, 5-[(acetyloxy)methyl]-, methyl ester

1-Hexene, 4,6,6,6-tetrachloro-

4H-BENZO[B][1,4]OXAZINE-4-ACETAMIDE,2-ETHYL-N-[(2-FLUOROPHENYL)METHYL]-2,3-DIHYDRO-6-METHYL-3-OXO-

606120-42-7

ACETAMIDE,N-(TERT-BUTYL)-2-[[2-(4-FLUOROPHENYL)-8-METHYL-4-QUINAZOLINYL]THIO]-

BUTANAMIDE,N-[4-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-5-YL)-5-METHYL-THIAZOL-2-YL]-2-METHYL-

Furo[2,3-g]quinoline-7-carboxylic acid,2,3,5,8-tetrahydro-8-oxo-5-(2-propenyl)-

4-PIPERIDINECARBOXAMIDE,1-(6,7-DIHYDRO-2-METHYL-5H-CYCLOPENTAPYRIMIDIN-4-YL)-N-(4-ETHOXYPHENYL)-

Benzeneethanimidic acid, 2-[(methylamino)carbonyl]hydrazide

5H-Thiazolo[2,3-b]quinazoline-3,5(2H)-dione

62473-05-6

ACETAMIDE,2-[[8-ETHYL-2-(4-FLUOROPHENYL)-4-QUINAZOLINYL]THIO]-N-(ISOPROPYL)-

Furo[2,3-g]quinoline-7-carboxylic acid,2,3,5,8-tetrahydro-8-oxo-5-(2-propynyl)-

ACETAMIDE,N-BUTYL-2-[[6-ETHYL-2-(3-METHYLPHENYL)-4-QUINAZOLINYL]THIO]-

Furo[2,3-g]quinoline-7-carboxylic acid,5-ethenyl-2,3,5,8-tetrahydro-8-oxo-, sodium salt

5H-1,4-Benzodiazepin-5-one,2-[[2-(dimethylamino)ethyl]amino]-3,4-dihydro-4-methyl-3-phenyl-,dihydrochloride

CARBAMIC ACID [(1S)-1-FORMYL-4-PENTENYL]-,TERT-BUTYL ESTER